Mark Klinger

4.3k total citations
30 papers, 1.7k citations indexed

About

Mark Klinger is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mark Klinger has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Mark Klinger's work include Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Mark Klinger is often cited by papers focused on Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Mark Klinger collaborates with scholars based in United States, Canada and France. Mark Klinger's co-authors include Malek Faham, Lawrence Fong, Yafei Hou, Edward Cha, Craig Cummings, Antoni Ribas, Robert J. Kay, Nigel Killeen, Jianbiao Zheng and Marissa Vignali and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Mark Klinger

30 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Klinger United States 18 872 696 504 274 200 30 1.7k
Janet Ayello United States 21 529 0.6× 705 1.0× 368 0.7× 341 1.2× 74 0.4× 117 1.3k
Paulo Vidal Campregher Brazil 12 950 1.1× 569 0.8× 323 0.6× 429 1.6× 65 0.3× 57 1.7k
Andries C. Bloem Netherlands 23 709 0.8× 628 0.9× 706 1.4× 792 2.9× 170 0.8× 57 1.9k
Jörg Westermann Germany 21 611 0.7× 476 0.7× 338 0.7× 340 1.2× 72 0.4× 85 1.2k
Andreas Roller Germany 16 867 1.0× 1.0k 1.5× 589 1.2× 661 2.4× 240 1.2× 33 2.1k
Robert E. Sobol United States 20 535 0.6× 797 1.1× 645 1.3× 257 0.9× 79 0.4× 43 1.8k
Joan Somja Belgium 21 397 0.5× 542 0.8× 452 0.9× 129 0.5× 204 1.0× 56 1.5k
HE Heslop United States 18 592 0.7× 460 0.7× 313 0.6× 485 1.8× 81 0.4× 32 1.4k
Gerald Wertheim United States 23 257 0.3× 523 0.8× 618 1.2× 405 1.5× 165 0.8× 83 1.5k
H Mizoguchi Japan 17 602 0.7× 506 0.7× 345 0.7× 353 1.3× 147 0.7× 54 1.4k

Countries citing papers authored by Mark Klinger

Since Specialization
Citations

This map shows the geographic impact of Mark Klinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Klinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Klinger more than expected).

Fields of papers citing papers by Mark Klinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Klinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Klinger. The network helps show where Mark Klinger may publish in the future.

Co-authorship network of co-authors of Mark Klinger

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Klinger. A scholar is included among the top collaborators of Mark Klinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Klinger. Mark Klinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Norheim, Gunnstein, Monika Sekelja, Amine Namouchi, et al.. (2023). Antigen presenting cell targeted T cell DNA vaccine inducing strong and specific cellular responses across multiple T cell epitopes of SARS-COV-2. The Journal of Immunology. 210(Supplement_1). 159.03–159.03. 1 indexed citations
2.
Emerson, Ryan, William S. DeWitt, Marissa Vignali, et al.. (2017). Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire. Nature Genetics. 49(5). 659–665. 287 indexed citations
3.
Oh, David Y., Jason Cham, Li Zhang, et al.. (2016). Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire. Cancer Research. 77(6). 1322–1330. 173 indexed citations
4.
Oh, David Y., Jason Cham, Li Zhang, et al.. (2016). Association between T cell repertoire diversification and both clinical response as well as toxicity following immune checkpoint blockade in metastatic cancer patients.. Journal of Clinical Oncology. 34(15_suppl). 3029–3029. 3 indexed citations
5.
Faham, Malek, Victoria Carlton, Martin Moorhead, et al.. (2016). Discovery of T Cell Receptor β Motifs Specific to HLA–B27–Positive Ankylosing Spondylitis by Deep Repertoire Sequence Analysis. Arthritis & Rheumatology. 69(4). 774–784. 71 indexed citations
6.
Klinger, Mark, Jianbiao Zheng, Kojo S.J. Elenitoba‐Johnson, et al.. (2015). Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation. Leukemia. 30(5). 1055–1061. 15 indexed citations
7.
Oki, Yasuhiro, Sattva S. Neelapu, Michelle A. Fanale, et al.. (2015). Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next‐generation sequencing approach. British Journal of Haematology. 169(5). 689–693. 40 indexed citations
8.
Klinger, Mark, François Pépin, Tobias Wittkop, et al.. (2015). Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing. PLoS ONE. 10(10). e0141561–e0141561. 74 indexed citations
9.
Logan, Aaron C., Malek Faham, Victoria Carlton, et al.. (2014). Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantation Relapse and Survival. Biology of Blood and Marrow Transplantation. 20(9). 1307–1313. 101 indexed citations
10.
Klinger, Mark, Katherine A. Kong, Martin Moorhead, et al.. (2013). Combining Next-Generation Sequencing and Immune Assays: A Novel Method for Identification of Antigen-Specific T Cells. PLoS ONE. 8(9). e74231–e74231. 29 indexed citations
11.
Cha, Edward, Yafei Hou, Mark Klinger, et al.. (2013). Effect of anti-CTLA-4 antibody treatment on T-cell repertoire evolution in treated cancer patients.. Journal of Clinical Oncology. 31(15_suppl). 3020–3020. 1 indexed citations
12.
Vij, Ravi, Amitabha Mazumder, Mark Klinger, et al.. (2013). Deep Sequencing Reveals Myeloma Cells in Peripheral Blood in Majority of Multiple Myeloma Patients. Clinical Lymphoma Myeloma & Leukemia. 14(2). 131–139.e1. 47 indexed citations
13.
Gawad, Charles, François Pépin, Victoria Carlton, et al.. (2012). Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. Blood. 120(22). 4407–4417. 89 indexed citations
14.
Klinger, Mark, Steven A. Chmura, & Nigel Killeen. (2010). Reporter Alleles that Inform on Differences in Cre Recombinase Expression. The Journal of Immunology. 184(11). 6170–6176. 8 indexed citations
15.
Fiedler, Walter, Birgit Ritter, Ruth Seggewiss, et al.. (2010). Phase I safety and pharmacology study of the EpCAM/CD3-bispecific BiTE antibody MT110 in patients with metastatic colorectal, gastric, or lung cancer.. Journal of Clinical Oncology. 28(15_suppl). 2573–2573. 15 indexed citations
16.
Klinger, Mark, Joong Kyu Kim, Steven A. Chmura, et al.. (2009). Thymic OX40 Expression Discriminates Cells Undergoing Strong Responses to Selection Ligands. The Journal of Immunology. 182(8). 4581–4589. 57 indexed citations
17.
Klinger, Mark, et al.. (2004). Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors. Oncogene. 24(16). 2695–2704. 33 indexed citations
18.
19.
Norment, Anne M., Lisa Bogatzki, Mark Klinger, et al.. (2003). Transgenic Expression of RasGRP1 Induces the Maturation of Double-Negative Thymocytes and Enhances the Production of CD8 Single-Positive Thymocytes. The Journal of Immunology. 170(3). 1141–1149. 26 indexed citations
20.
Zohn, Irene E., Mark Klinger, Xantha Karp, et al.. (2000). G2A is an oncogenic G protein-coupled receptor. Oncogene. 19(34). 3866–3877. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janet Ayello Breakdown of academic impact, for papers by Paulo Vidal Campregher Breakdown of academic impact, for papers by Andries C. Bloem Breakdown of academic impact, for papers by Jörg Westermann Breakdown of academic impact, for papers by Andreas Roller Breakdown of academic impact, for papers by Robert E. Sobol Breakdown of academic impact, for papers by Joan Somja Breakdown of academic impact, for papers by HE Heslop Breakdown of academic impact, for papers by Gerald Wertheim Breakdown of academic impact, for papers by H Mizoguchi
Rankless by CCL
2026